Tuesday Night IBS

We recognize that food plays a role in managing IBS and other digestive conditions and making informed choices could provide a better quality of life for you or your loved ones. Kate Scarlata MPH, RDN who is a clinical expert in the research and practical use of FODMAP for managing GI symptoms, invited four companies to speak about their products to help you make food choices easier.
Intoleran are digestive experts in enzymes and supplements for intestinal support which can help you enjoy food again.
Gourmend Foods provides cooking essentials that replace symptom causing ingredients with the highest quality, low FODMAP alternatives.
tuut app, makes tracking food and lifestyle factors quick and painless with voice memos and photos. Then, AI does the hard part tracking everything for you.
Verve Market personalizes local grocery shopping by analyzing hundreds of thousands of products at the ingredient level to match you with the best options based on your dietary needs with a fully curated experience. 
This independent medical educational webinar is supported by Intoleran, Gourmend Foods, tuutapp.net, and Verve Market
Learn more about Tuesday Night IBS at TuesdayNightIBS.com
The information included in this podcast is not a substitute for professional medical advice, examination, diagnosis or treatment.  Always seek the advice of your physician or other qualified health care provider before starting any new treatment or making changes to existing treatment.

This special World IBS Day 2026 webinar features the GI experts: Andrea Shin, MD a gastroenterologist at UCLA Health who serves on the Rome V Bowel Disorders Committee, Sarah Ballou, PhD a clinical psychologist specializing in gastropsychology at Beth Israel Deaconess Medical Center who serves as Co‑Chair of the GastroPsychology Section of the Rome Foundation and Heidi Staudacher, PhD an advanced accredited practicing Dietitian and Associate Professor (Research) at Monash University who serves on the Rome V DGBI Treatment Trials committee.
This independent medical educational webinar is co-presented by the Rome Foundation and supported by Ardelyx, Salix Pharmaceuticals, Modify Health, Monash FODMAP and tuutapp.net
Learn more about Tuesday Night IBS at TuesdayNightIBS.com
The information included in this podcast is not a substitute for professional medical advice, examination, diagnosis or treatment.  Always seek the advice of your physician or other qualified health care provider before starting any new treatment or making changes to existing treatment.

Probiotics could help manage IBS symptoms like bloating, gas, and abdominal pain by balancing gut flora, strengthening the gut barrier, and improving motility, Benefits vary by strain and individual. Our GI experts: John Damianos MD a clinical fellow in Gastroenterology and Hepatology at the Mayo Clinic who also serves on the Scientific Advisory Committee of the Alliance for Education on Probiotics and Kate Scarlata MPH, RDN a clinical expert in the research and practical use of diet and FODMAP for managing GI symptoms, discussed this topic.
This independent medical educational webinar is supported by ExeGI Pharma, the makers of the probiotic Visbiome.
Learn more about Tuesday Night IBS at TuesdayNightIBS.com
The information included in this podcast is not a substitute for professional medical advice, examination, diagnosis or treatment.  Always seek the advice of your physician or other qualified health care provider before starting any new treatment or making changes to existing treatment.

We had a discussion about a new theory related to gravity and how could it be shaping our guts, minds and stomachs. Dr. Brennan Spiegel was joined by Dr. Megan Riehl, PsyD and Kate Scarlata, MPH, RDN to unravel if gravity could actually be shaping our guts, minds and stomachs and might IBS be a symptom of this dysregulation.

This Tuesday Night IBS webinar features Dr. Kyle Staller an adult gastroenterologist, and Dr. Thomas Wallach a pediatric gastroenterologist. They both discuss how to manage IBS-C in adults and children and whether you should discuss new treatments with your own doctor.

Listen to our 2025 webinar with Dr. Mark Pimentel of MAST at Cedars-Sinai. Dr. Pimentel discusses the newest research on SIBO, IBS and present mock case studies.Mark Pimentel, MD, is the executive director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai and in collaboration with Ruchi Mathur, MD, whose work focuses on links between metabolic disease and gut microbiome, and Ali Rezaie, MD, whose innovative work in GI motility improves the wellbeing of patients, as part of the MAST team they focus on the development of drugs, diagnostic tests and devices related to conditions of the microbiome. - Pimentel Lab

In this special crossover podcast episode, Tuesday Night IBS co-hosts Jeffrey Roberts MSEd BSc and Erica Dermer are joined live by Dr. William Chey, Amanda Lynett MS RDN and Kate Scarlata MPH RDN at FOOD The Main Course in Ann Arbor, MI. This episode discusses the following topics:The evolution of FOOD: The Main Course over the years and why dietitians should attendThe role and benefit of incorporating GI dietitians into integrated care modelsThe evolution of GI dietitians at major GI meetings like DDWIBS, your diet and the microbiomeStress, your diet and IBSGLP-1 use and increased GI symptomsCombating GI misinformation onlineOstomies for severe constipation?Check out even more episodes at Healio's Gut Talk Podcast website and submit comments and questions to guttalkpodcast@healio.com. Check out Tuesday Night IBS for more evidence-based webinars and podcasts at TuesdayNightIBS.com.

In this special crossover podcast episode, Tuesday Night IBS host Jeffrey Roberts, MSEd, BSc, and Kate Scarlata, MPH, RDN, are joined live by William Chey, MD, and Amanda Lynett, MS, RDN, at FOOD the Main Course Conference in Ann Arbor, MI.Amanda Lynett MS, RDN, is a registered dietitian with her masters. Amanda is with the Division of Gastroenterology at Michigan Medical in Ann Arbor.Jeffrey Roberts, MSEd, BSc, is a patient advocate and creator of the first website for IBS sufferers. He is the co-founder of Tuesday Night IBS.Kate Scarlata, MPH, RDN, is a US-based dietitian with over 30 years of experience. Kate’s expertise is in gastrointestinal disorders and food intolerance.We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow uson X @HealioGastro @sameerkberry @umfoodoc. For more Tuesday Night IBS, be sure check out TuesdayNightIBS.com and to follow and subscribe to their podcast.Disclosures: Chey and Roberts report no relevant financial disclosures. Scarlata reports stock options with Epicured LLC and FODY Food Company, financial support from Dr. Schar, Mahana Therapeutics, Nestle Health Science, Olipop, Pendulum, QOL Medical.

On this special episode of Tuesday Night IBS, we talk with the co-principal investigator, Alex Ford, MD, from Leeds University in the UK, about the ATLANTIS trial of Amitriptyline for irritable bowel syndrome (IBS) in primary care, which was funded by the Health Technology Assessment program of the National Institute for Health and Care Research and the TRITON trial using Ondansetron to manage irritable bowel syndrome with diarrhea.Dr. Alex Ford is a Professor and Honorary consultant gastroenterologist at St. James’s University Hospital, Leeds, UK. His main interest is in the epidemiology, diagnosis, and treatment of disorders of gut-brain interaction, such as irritable bowel syndrome and functional dyspepsia. He is an Associate Editor for Alimentary Pharmacology & Therapeutics. He has published over 450 peer-reviewed articles, including original scientific papers in The Lancet, JAMA, BMJ, Gastroenterology, Gut, Archives of Internal Medicine, and The American Journal of Gastroenterology.

Join us as experts Dr. Anthony Lembo and Dr. Lin Chang, discuss the future of IBS management with more precise testing and tailored treatments and the benefits of a new diagnostic test for IBS, InFoods IBS.